tbuckley/cabot-search huggingface dataset:
Active Study: Impact of Voxelotor on Sleep Quality, Physical Activity, and Patient-Reported Outcomes
Authors: Nirmish Shah, Clark Brown, Biree Andemariam, Modupe Idowu, Alexander Glaros, Jeffrey Glassberg, Robert M Cronin, Barbara Moehring, Carolyn Hoppe, Sandy Dixon, Deepa Manwani
Journal: Blood (2022)
Thrombocytopenia in a Mouse Model of Pancreatic Cancer
Authors: Michelle M. Luo, Yaqiu Sang, Maria N. Barrachina, Andrew P. Stone, Keely G. Davey, Yi Yang, Lori A. Holle, Tomohiro Kawano, Nigel Mackman, Matthew J. Flick, Kellie R. Machlus, Alisa S. Wolberg
Journal: Blood (2022)
Graft-Versus-Leukemia Effect Is Independent from Graft-Versus-Host Disease Following Ptcy-Based HLA-Haploidentical Transplantation
Authors: Frederic Baron, Myriam Labopin, Johanna Tischer, Anna Maria Raiola, Jan Vydra, Didier Blaise, Patrizia Chiusolo, Friedrich Stölzel, Renato Fanin, Patrice Chevallier, Arnon Nagler, Fabio Ciceri, Mohamad Mohty
Journal: Blood (2022)
Elucidating the Mechanism of Action (MOA) of Navtemadlin, an MDM2 Inhibitor, and Its Synergy with Gilteritinib in Myeloid Malignancies
Authors: Sara Elgamal, Tracy Clevenger, Michael Gulrajani, Jean Cheung, Erin G. Jeremy, Sydney Fobare, Shelley Orwick, Ellen J. Sass, Erin Hertlein, Karilyn T. Larkin, Todd Covey, Wayne P. Rothbaum, John C. Byrd
Journal: Blood (2022)
Toxicity and Outcomes in Octo- and Nonagenarians with AML Treated with Venetoclax and Hypomethylating Agent Therapy
Authors: Ellen Madarang, Jillian Lykon, Wei Zhao, Mikkael A. Sekeres, Terrence Bradley, Namrata Sonia Chandhok, Justin Taylor, Tulay Koru-Sengul, Sunil G. Iyer, Jacopo Nanni, Cristina Papayannidis, Ryan M Miller, Ashwin Kishtagari, Michael R. Savona, Jason Gilbert, Daniel A. Pollyea, David A. Sallman, Najla Al Ali, Rami S. Komrokji, Justin Watts
Journal: Blood (2022)
Early Dynamics of C-Reactive Protein Predict Risk of Venous Thromboembolism in Patients with Cancer Treated with Immune Checkpoint Inhibitors
Authors: Florian Moik, Jakob Riedl, Dominik Barth, Wei-Shin Evelyn Chan, Sarah Wiedemann, Christoph Höller, Thorsten Fuereder, Philipp Jost, Ingrid Pabinger, Matthias Preusser, Cihan Ay
Journal: Blood (2022)
Higher Proportions of Monocytic-Myeloid-Derived Suppressive Cells (mMDSC) before Allotransplant Predict Relapse in Acute Leukemia Patients
Authors: Pierre Peterlin, Marie C Bene, Maxime Jullien, Thierry Guillaume, Amandine Le Bourgeois, Alice Garnier, Camille Debord, Marion Eveillard, Patrice Chevallier
Journal: Blood (2022)
Generation of Human Induced Pluripotent Stem Cell-Derived Bone Marrow Organoids
Authors: Stephanie Frenz, Isabel Goek, Maximilian Buser, Kirill Salewskij, Savannah Fairley, Raffaele Conca, Nicole Drexler, Gustav Jonsson, Moritz Thomas, Yoko Mizoguchi, Martina Rudelius, Thomas Heuser, Carsten Marr, Josef M Penninger, Christoph Klein
Journal: Blood (2022)
The Clinico-Genomic Landscape of Induction Failure in Childhood and Young Adult T-Cell Acute Lymphoblastic Leukemia (T-ALL)
Authors: David O'Connor, Jonas Demeulemeester, Lucia Conde, Amy A. Kirkwood, Kent Fung, Foteini Papaleonidopoulou, Gianna Bloye, Nadine Farah, Sunniyat Rahman, Jeremy Hancock, Caroline Bateman, Sarah Inglott, Jon Mee, Javier Herrero, Peter Van Loo, Anthony V. Moorman, Ajay Vora, Marc R. Mansour
Journal: Blood (2022)
Abnormal Free Light Chains in Individuals with African Ancestry Screened for Monoclonal Gammopathy: Definition of New Reference Range Accounting for Renal Function and Race
Authors: Luca Bertamini, Jean-Baptiste Alberge, Habib El-Khoury, David J. Lee, Ciara Murphy, Grace Fleming, Maya I. Davis, Jacqueline Perry, Christian J. Cea-Curry, Audrey Pentz, Thulisile Hlubi, Natalie Smyth, D.J. Sakrikar, Mark C. Perkins, Stephen Harding, Derek Troske, Gad Getz, Timothy R. Rebbeck, Maureen Joffe, Catherine R. Marinac, Nelson Leung, Carl Wenlong Chen, Irene Ghobrial
Journal: Blood (2022)
The Optimized HLH Inflammatory Index Is Associated with a Higher Stage of Lymphoma, but an Unexpected High Mortality Associated with Inflammation
Authors: Adi Zoref-Lorenz, Jun Murakami, Liron Hofstetter, Uri Abadi, Swaminathan P. Iyer, Shehab Fareed Mohamed, Abd El Haleem Natour, Shiri Weinstein, Joanne Yacobovich, Shai Izraeli, Sarah Nikiforow, Ronit Gurion, Inbar Cohen, Oren Pasvolsky, Pia Raanani, Arnon Nagler, Nancy Berliner, Naval Daver, Martin H. Ellis, Gaurav Goyal, Michael B Jordan
Journal: Blood (2022)
Intracellular IL-23 Receptor (IL-23R) Is Necessary for AML Viability and Regulates Mitotic Spindle and Centrosome Formation
Authors: Nathan Duong, Dilshad H. Khan, Geethu Emily Thomas, Rose Hurren, Jong Bok Lee, Jonathan St-Germain, Lily Drimmer, Yongran Yan, Neil MacLean, Marcela Gronda, Brandon D Brown, Brian Raught, Andrea Arruda, Mark D. Minden, Li Zhang, Steven M. Kornblau, Vito Spadevecchio, Aaron D. Schimmer
Journal: Blood (2022)
An Updated Safety and Efficacy Analysis of Venetoclax Plus Daratumumab and Dexamethasone in an Expansion Cohort of a Phase 1/2 Study of Patients with t(11;14) Relapsed/Refractory Multiple Myeloma
Authors: Jonathan L. Kaufman, Hang Quach, Rachid C. Baz, Annette Juul Vangsted, Shir-Jing Ho, Simon J Harrison, Torben Plesner, Philippe Moreau, Simon D. Gibbs, Eva Medvedova, Muhammad Jalaluddin, Jeremy A. Ross, Leanne Lash Fleming, Yan Luo, Nizar Jacques Bahlis
Journal: Blood (2022)
The FLT3-ITD Allelic Ratio and NPM1 Mutation Do Not Impact Outcomes in AML Patients with FLT3-ITD after Allo-HSCT: A Retrospective Propensity-Score Matching Study
Authors: Cuiyan Zhou, Fengmei Zheng, Lanping Xu, Xiaohui Zhang, Yingjun Chang, Xiao-Dong Mo, Yuqian Sun, Yu Wang, Xiao-Jun Huang
Journal: Blood (2022)
Efficacy and Safety of Ruxolitinib for Treatment of Symptomatic Chronic Myelomonocytic Leukemia (CMML): Results of a Multicenter Phase II Clinical Trial
Authors: Eric Padron, Sara M Tinsley-Vance, Amy E. DeZern, Hetty E. Carraway, Marlise R. Luskin, Gail J. Roboz, Onyee Chan, Meagan Horton, Aaron T. Gerds, David A. Sallman, Andrew Kuykendall, David Steensma, Maria E Balasis, Jeffrey E. Lancet, Mikkael A. Sekeres, Rami S. Komrokji
Journal: Blood (2022)
Chronic Graft Versus Host Disease Detected By Tissue-Specific Cell-Free DNA Methylation Biomarkers
Authors: Batia Avni, Daniel Neiman, Elior Shaked, Sigal Grisariu Greenzaid, Mona Kuzli, Andrea Fracchia, Polina Stepensky, Tsila Zuckerman, Ahinoam Lev-Sagie, Ilana Fox-Fisher, Sheina Piyanzin, Joshua Moss, Benjamin Glaser, Ruth Shemer, Yuval Dor
Journal: Blood (2022)
Sars-Cov-2 T-Cell Responses after One or Two COVID-19 Vaccine Boosters in Allogeneic Transplant Recipients
Authors: Beatrice Clemenceau, Amandine Le Bourgeois, Thierry Guillaume, Marianne Coste-Burel, Pierre Peterlin, Alice Garnier, Maxime Jullien, Jocelyn Ollier, Marie C. Bene, Patrice Chevallier
Journal: Blood (2022)
Identification of Pyroptosis-Related Signature and Development of a Novel Prognostic Model in Diffuse Large B-Cell Lymphoma
Authors: Liemei Lv, Yu Zhang, Yiqing Cai, Zhuoya Yu, Xueling Ge, Xiaosheng Fang, Cong Wang, Ran Kong, Xin Wang, Xiangxiang Zhou
Journal: Blood (2022)
Development of a Novel Chromatin Activation Score As a Powerful Independent Prognostic Factor in Chronic Lymphocytic Leukemia
Authors: Vicente Chapaprieta, Alba Maiques-Diaz, Guillem Clot, Ferran Nadeu, Judith Mateos-Jaimez, Anna Vidal, Stella Charalampopoulou, Martí Duran-Ferrer, Romina Royo, Junyan Lu, Thorsten Zenz, Julio Delgado, Armando Lopez-Guillermo, Elías Campo, José I. Martín-Subero
Journal: Blood (2022)
Administration of Obinutuzumab, and Not Rituximab, during Induction and Maintenance for Follicular Lymphoma Increases the Likelihood of Developing Delayed Neutropenia
Authors: Shimrit Harlev, Nashwa Fadaos, Tehila Azoulay, Ronit Leiba, Nurit Horesh, Tsofia Inbar, Netanel A. Horowitz, Inna Tsoran-Rosenthal, Noa Lavi, Eldad J. Dann, Tsila Zuckerman
Journal: Blood (2022)
Eltrombopag in Pediatric Patients with Previously Untreated or Refractory/Relapsed Severe Aplastic Anemia: The Phase II Escalate Trial
Authors: Akiko Shimamura, Alexey Maschan, Carolyn Bennett, Jason E Farrar, Sujith Samarasinghe, Brigitte Strahm, Winfred C. Wang, Adrianna Vlachos, Charlotte M. Niemeyer, Timothy S. Olson, Denise D'Alessio, Elise Burmeister Getz, Tomasz Lawniczek, Yunnan Xu, David A. Williams
Journal: Blood (2022)
Clinico-Molecular Risk Factors and Management of Thrombosis in a Large Real-Life Cohort of Patients with Paroxysmal Nocturnal Hemoglobinuria in the New Era of Anti-Complement Inhibitors and Doacs
Authors: Carmelo Gurnari, Hussein Awada, Mai Aly, Danai Dima, Fauzia Ullah, Naomi Kawashima, Yasuo Kubota, Ceylan Colak, Valeria Visconte, Simona Pagliuca, Bhumika J. Patel, Taha Bat, Jaroslaw P. Maciejewski
Journal: Blood (2022)
Systematic Evaluation of AML-Associated Antigens Identifies Novel Anti-U5 snRNP200 Therapeutic Antibodies for the Treatment of AML
Authors: Katherine Knorr, Caroline Erickson, Eric Wang, Jahan Rahman, Xiaoli Mi, Sydney Lu, Nina Fox, Alex Penson, Simon Hogg, Robert Stanley, Daichi Inoue, David Knorr, Jeffrey Ravetch, Omar Abdel-Wahab
Journal: Blood (2022)
Cell Mass and Stiffness As Integrative Biomarkers of Cell State in Mantle Cell Lymphoma
Authors: Lydie Debaize, Ye Zhang, Adam Langenbucher, Huiyun Liu, Michelle Ramseier, Nolawit Mulugeta, Nezha Senhaji, Robert A. Redd, Martin J. Aryee, Alex K. Shalek, David M. Weinstock, Scott R. Manalis, Mark A. Murakami
Journal: Blood (2022)
Modeling and Simulation in Support of Odronextamab Subcutaneous Dose Selection for Adult Patients with Indolent or Aggressive Non-Hodgkin Lymphoma
Authors: Min Zhu, Srikanth R. Ambati, Hesham Mohamed, Masood Khaksar Toroghi, Hong Yan, Aafia Chaudhry, John D. Davis
Journal: Blood (2022)
Azacitidine and Panobinostat Overcome Bone Marrow Microenvironment-Induced Chemoprotection in <i>KMT2A-</i>rearranged Pediatric AML
Authors: Kara Lehner, Anilkumar Gopalakrishnapillai, E. Anders Kolb, Sonali P. Barwe
Journal: Blood (2022)
White Matter Injury in Sickle Cell Mice Is Associated with Reduced Neurocognitive Function and Activation of Astrocytes
Authors: Rimi Hazra, Hongjan Pu, Lesley M. Foley, T. Kevin Hitchens, Lynda Little-Ihrig, Samit Ghosh, Solomon Fiifi Ofori-Acquah, Xiaoming Hu, Enrico M. Novelli
Journal: Blood (2022)
XPO1 Inhibitor (ATG-010) Plus GemOx Regimen for Heavily Pretreated Patients with Relapsed or Refractory (R/R) T and NK-Cell Lymphoma：Updates of the Phase Ib Touch Study
Authors: Huiqiang Huang, Yan Gao, Huilai Zhang, Keshu Zhou, Jianqiu Wu, Zhen Cai, Hongmei Jing, LEI Fan, Sai Lou, Yizhou Fei, Aihua Wang, Kevin Lynch
Journal: Blood (2022)
Epichaperome Inhibition Targets Kinase and <i>TP53</i> Mutant Therapy Resistant AML
Authors: Bing Z Carter, Po Yee Mak, Wenjing Tao, Lauren B Ostermann, Yuki Nishida, Naveen Pemmaraju, Steffen Boettcher, Elizabeth J Shpall, Gabriela Chiosis, Georgios Karras, Barbara Wallner, Robert A Morgan, Michael Andreeff
Journal: Blood (2022)
Dose Escalation and Expansion of Abbv-383 in Combination with Anti-Cancer Regimens in Relapsed or Refractory Multiple Myeloma
Authors: Cesar Rodriguez, Katja Weisel, Rachid C. Baz, Akshanth R. Polepally, Jeremy A. Ross, Ziyi Jin, Kristin D'Amico, Orlando F. Bueno, Leanne Lash Fleming, Peter M. Voorhees
Journal: Blood (2022)
Haplo-Cord HCT Versus Haplo-Identical HCT for Acute Leukemia Patients Not in Remission: A Multicenter Study
Authors: Mimi Xu, Jinjin Zhu, Yishan Ye, Xiaoli Li, Biqi Zhou, Yiyang Ding, Yi Fan, Yuqing Tu, Yang Xu, Jia Chen, He Huang, Depei Wu
Journal: Blood (2022)
Novel Drugs in the Treatment of Steroid Refractory Acute Graft Versus Host Disease
Authors: Iuliia Kovalenko, Tabinda Saleem, Babray Laek, Rimsha Ali, Taaha Mirza, Asmi Chattaraj, Ahsan Wahab, Asma Tameez, Hafiz Qurashi, Konstantin Golubykh, Martin Cuevas, Wern Lynn Ng, Yijin Wert, Rafiullah Khan
Journal: Blood (2022)
High MN1 Expression Is Associated with an Lspc-Enriched Phenotype and Glycolysis Representing a New Vulnerability in Acute Myeloid Leukemia
Authors: Diego Pereira-Martins, Noortje van Dijk, Isabel Weinhaeuser, Douglas RA Silveira, Juan Coelho Da Silva, Thiago M Bianco, César Alexander Ortiz, Fabiola Traina, Lorena L Figueiredo-Pontes, Emanuele Ammatuna, Lynn Quek, Gerwin A. Huls, Antonio R. Lucena-Araujo, Eduardo M Rego, Jan Jacob Schuringa
Journal: Blood (2022)
Outcome of Haematopoietic Cell Transplantation in 813 Children with Fanconi Anaemia: A Study on Behalf of the EBMT Severe Aplastic Anaemia Working Party and Paediatric Disease Working Party
Authors: Su Han Lum, Sujith Samarasinghe, Dirk-Jan Eikema, Brian Piepenbroek, Arnaud Dalissier, Mouhab Ayas, Ashrafsadat Mousavi, Rose-Marie Hamladji, Akif Yesilipek, Jean-Hugues Dalle, Savas Kansoy, Franco Locatelli, Duygu Çetinkaya, Marc Bierings, O. Alphan Kupesiz, Abdelghani Tbakhi, Elena Skorobogatova, Gülyüz Öztürk, Maura Faraci, Yves Bertrand, Pamela Evans, Selim Carbacioglu, Carlo Dufour, Antonio Risitano, Robert F Wynn, Régis Peffault de Latour
Journal: Blood (2022)
Monitoring the in-Vivo Expansion and Persistence of CAR-T Cells As a Tool to Help Decision Making in Patients with Aggressive B-Cell Lymphoma
Authors: Daniel Fürst, Christine Neuchel, Adela Neagoie, Elisa Amann, Immanuel Rode, Angela Krauss, Hubert Schrezenmeier, Verena Wais, Hartmut Döhner, Andreas Viardot, Elisa Sala
Journal: Blood (2022)
Untargeted Metabolomics on Dried Blood Spots of Patients with Sickle Cell Disease Treated with the Pyruvate Kinase Activator Mitapivat
Authors: Myrthe J. van Dijk, Sigrid van der Veen, Minke A.E. Rab, Brigitte A. van Oirschot, Jennifer Bos, Cleo Derichs, Anita W. Rijneveld, Marjon H. Cnossen, Erfan Nur, Bart J. Biemond, Marije Bartels, Judith J.M. Jans, Richard van Wijk, Eduard J. van Beers
Journal: Blood (2022)
Enriched learning: behavior, brain, and computation
Authors: Brian Mathias, Katharina von Kriegstein
Journal: Trends in Cognitive Sciences (2022)

The presence of complementary information across multiple sensory or motor modalities during learning, referred to as multimodal enrichment, can markedly benefit learning outcomes. Why is this? Here, we integrate cognitive, neuroscientific, and computational approaches to understanding the effectiveness of enrichment and discuss recent neuroscience findings indicating that crossmodal responses in sensory and motor brain regions causally contribute to the behavioral benefits of enrichment. The findings provide novel evidence for multimodal theories of enriched learning, challenge assumptions of longstanding cognitive theories, and provide counterevidence to unimodal neurobiologically inspired theories. Enriched educational methods are likely effective not only because they may engage greater levels of attention or deeper levels of processing, but also because multimodal interactions in the brain can enhance learning and memory.
Polyploidy Is Necessary for Apoptotic Cell Death in <i>TP53</i>-Mut AML in Response to Polo-like-Kinase 4 (PLK4) Inhibition and Results in Caspase 3 Cleavage
Authors: Edward Ayoub, Akhil Marupudi, Yuki Nishida, Rafael Heinz Montoya, Vakul Mohanty, Wencke Walter, Mark R Bray, Tallie Patsilevas, Steffen Boettcher, Ghayas C. Issa, Ken Chen, Torsten Haferlach, Gautam Borthakur, Michael Andreeff
Journal: Blood (2022)
CXCR4 Promotes Bortezomib Resistance and Regulates Metabolic Reprogramming, Activating Both Glycolytic and Oxphos Pathways in Multiple Myeloma
Authors: Katia Beider, Noy Sharvit Boaron, Valeria Voevoda, Olga Ostrovsky, Ivetta Danylesko, Avichai Shimoni, Amnon Peled, Arnon Nagler
Journal: Blood (2022)
Comparison of Hematopoietic Stem Cell Transplantation and Immunosuppressive Therapy for Patients with Severe Hepatitis-Associated Aplastic Anemia
Authors: Xiaoyu Zhang, Wenrui Yang, Jialin Wei, Rongli Zhang, Guixin Zhang, Xin Chen, Yong Huang, Yingchang Mi, Sizhou Feng, Mingzhe Han, Li Zhang, Yi He, Erlie Jiang
Journal: Blood (2022)
<i>RUNX1</i> Mutated AML and MDS: Similarities, Differences and Molecular Factors Leading to Disease Progression
Authors: Anna Stengel, Manja Meggendorfer, Wencke Walter, Constance Baer, Niroshan Nadarajah, Stephan Hutter, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach
Journal: Blood (2022)
Clinical Significance of a Miniscule GPI(-) Granulocyte Population in Patients with Bone Marrow Failure
Authors: Dung Cao Tran, Kohei Hosokawa, Hiroki Mizumaki, Yoshitaka Zaimoku, Hiroyuki Takamatsu, Hirohito Yamazaki, Ken Ishiyama, Toshihiro Miyamoto, Shinji Nakao
Journal: Blood (2022)
Modeling Progression of CML Using Mutagenized Patient-Derived Induced Pluripotent Stem Cells (iPSCs): Potential Tool for Discovering Novel Therapeutic Targets
Authors: Jusuf Imeri, Christophe Desterke, Gladys Telliam, Paul Marcoux, Nathalie Sorel, Safa Sanekli, Sylvain Barreau, Yücel Erbilgin, Theodoros Latsis, Patricia Hugues, Emilie Cayssials, Jean Claude Chomel, Annelise Bennaceur Griscelli, Ali G Turhan
Journal: Blood (2022)
Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Congenital Amegakaryocytic Thrombocytopenia, a PDWP/EBMT Study
Authors: Clemence Aldebert, Mony Fahd, Jacques-Emmanuel Galimard, Ibrahim A. Ghemlas, Marco Zecca, Juliana Silva, Alexander Mohseny, Alphan Kupesiz, Rose-Marie Hamladji, Nuno Miranda, Tayfun Gungor, Robert F Wynn, Pietro Merli, Mikael Sundin, Maura Faraci, Cristina Díaz-de-Heredia, Birgit Burkhardt, Victoria Bordon, Charlotte Jubert, Peter Bader, Marianne Ifversen, Concepcion Herrera Arroyo, Natalia Maximova, Susana Riesco, Jerry Stein, Arnaud Dalissier, Franco Locatelli, Krzysztof Kalwak, Jean-Hugues Dalle, Selim Corbacioglu
Journal: Blood (2022)
Association between Patient-Reported Social Determinant of Health Outcomes and a Social Genomics Profile in Allogeneic Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research (CIBMTR) Analysis
Authors: Mallory Taylor, Steve W. Cole, Joelle Strom, Ruta Brazauskas, K. Scott Baker, Rachel Phelan, David K. Buchbinder, Betty K. Hamilton, Helene Schoemans, Jennifer M Knight
Journal: Blood (2022)
The Rorɣ/SREBP2 Pathway Is a Master Regulator of Cholesterol Metabolism and Serves As Potential Therapeutic Target in <i>T(4;11)</i> Leukemia
Authors: Estelle Erkner, Thomas Hentrich, Rahel Fitzel, Hildegard Keppeler, Fulya Korkmaz, Johan Jeong, Julia Schulze-Hentrich, Claudia Lengerke, Dominik Schneidawind, Corina Schneidawind
Journal: Blood (2022)
Single Cell Transcriptomic Analysis of the Bone Marrow Microenvironment Uncovers a Role for Antigen Presentation Processes in MDS/AML Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
Authors: Jennifer Rivière, Mark van der Garde, Judith S. Hecker, Michèle C. Buck, Florian Bassermann, Mareike Verbeek, Katharina S. Goetze
Journal: Blood (2022)
Addition of Ruxolitinb to Corticosteroids As First-Line Therapy for High-Risk Acute Graft Versus Host Disease in Allogeneic Peripheral Blood Stem Cell Transplantation
Authors: Liping Dou, Yanli Zhao, Lei Deng, Fang Zhou, Nan Wang, Xiangshu Jin, Fei Li, Liangding Hu, Daihong Liu
Journal: Blood (2022)
A Real-World Population Pharmacokinetic (PK) Study of Two Recombinant Factor VIII (rFVIII) Concentrates in Boys with Severe Hemophilia a without Inhibitors
Authors: Viviane Grassmann, Dagmar M Hajducek, Andrea N Edginton, Vanessa Bouskill, Christine Brown, Manuel Carcao, David Lillicrap, Roxy H O'Rourke, Roona Sinha, Jayson Stoffman, Cindy Wakefield, Margaret L. Rand, Victor Blanchette
Journal: Blood (2022)
Real World Favourable Experience of Haematopoietic Stem Cell Transplantation during Acute Coronavirus Disease 2019 in a Highly-Vaccinated Asian Population
Authors: Christopher Tham, Yeh Ching Linn, Lawrence Ng, Jeffrey Quek, Aloysius YL Ho, Francesca Lim, Yunxin Chen, William YK Hwang, Jing Jing Lee, Gina Gan, Jasmine Shimin Chung, Ban Hock Tan, Thuan Tong Tan, Hein Than
Journal: Blood (2022)
HLA-Haploidentical Vs Mismatched Unrelated Donor Transplants with Post-Transplant Cyclophosphamide-Based Gvhd Prophylaxis for AML and MDS: Is There a Winner?
Authors: Dipenkumar Modi, Maya Shatta, Seongho Kim, Abhinav Deol, Andrew Kin, Asif Alavi, Lois Ayash, Voravit Ratanatharathorn, Joseph P. Uberti
Journal: Blood (2022)
Pre-Transplant Multiparameter Flow Cytometric Measurable Residual Disease in Acute Myeloid Leukemia As an Independent Prognostic Factor for Survival after Myeloablative Allogeneic Hematopoietic Cell Transplantation
Authors: Anna Czyz, Malgorzata Maria Sobczyk Kruszelnicka, Tomasz Czerw, Sebastian Giebel, Magdalena Dutka, Agnieszka Piekarska, Maria Bieniaszewska, Jan Zaucha, Maciej Majcherek, Marta Anna Sobas, Tomasz Wróbel, Barbara Nasilowska-Adamska, Halaburda Kazimierz, Andrzej Szczepaniak, Lidia Gil, Anna Kopinska, Grzegorz Helbig, Sylwia Bartyzel-Palinska, Patrycja Mensah-Glanowska, Agnieszka Tomaszewska, Agnieszka Pluta, Elzbieta Patkowska, Jolanta Wozniak, Agnieszka Balana, Donata Szymczak, Jolanta Parulska, Ameenah Sukkur, Andi Rustani, Nuria Mencia Trinchant, Pinkal Desai, Michael Samuel, Justin D. Kaner, Ellen Ritchie, Monica L. Guzman, Gail J. Roboz, Agnieszka Wierzbowska
Journal: Blood (2022)
Primary Hepatic Lymphoma: Role of Low-Dose Radiotherapy at a Single Institution with Genetic Characterization and Paired Literature Review
Authors: Jennifer Ma, Remy Daou, Josiane Bou Eid, Jisun Lee, Beatrice Fregonese, Joe El-Khoury, Neil Ari Wijetunga, Harper Hubbeling, Kathryn R. Tringale, Emily S. Lebow, Reith Sarkar, Brandon S. Imber, Joachim Yahalom, Carla Hajj
Journal: Blood (2022)
Cladribine with Low Dose Cytarabine for Unfit Patients: A Safe and Effective Approach with Low Early Mortality in a Population Ineligible for Clinical Trials
Authors: Sai Prasad Desikan, Hagop Kantarjian, Elias Jabbour, Kelly S. Chien, Guillermo Montalban-Bravo, Yesid Alvarado, Gautam Borthakur, Ghayas C. Issa, Naval Daver, Naveen Pemmaraju, Musa Yilmaz, Danielle Hammond, Abhishek Maiti, Courtney D. DiNardo, Farhad Ravandi, Guillermo Garcia-Manero, Tapan M. Kadia
Journal: Blood (2022)
Association of Novel Urinary Protein Biomarkers with Persistent Albuminuria in Patients with Sickle Cell Disease
Authors: Laila Elsherif, Praghalathan Kanthakumar, Jeremiah Afolabi, Ayesha Mukhopadhyay, Matthew P. Smeltzer, Adebowale Adebiyi, Kenneth I. Ataga
Journal: Blood (2022)
MYCN Regulates Cell Survival Via EIF4G1 in Inv(16) Acute Myeloid Leukemia
Authors: Philomina Sona Peramangalam, Sridevi Surapally, Shikan Zheng, Robert Burns, Nan Zhu, Sridhar Rao, Carsten Müller-Tidow, John Anto Pulikkan
Journal: Blood (2022)
Personalization of Clotting Factor VIII Replacement Therapy Based on Population Pharmacokinetics in Adult Patients with Severe Hemophilia a Who Frequently Switch Factor VIII Concentrates
Authors: Jerzy Windyga, Edyta Odnoczko, Ewa Stefanska-Windyga, Beata Baran, Anna Sikorska, Magdalena Gorska-Kosicka, Janusz Zawilski, Magdalena Letowska
Journal: Blood (2022)
Prevalence, Clinical and Molecular Features, and Prognostic Value of Tetraploidy/Near-Tetraploidy in Patients with Acute Myeloid Leukemia
Authors: Leo Ruhnke, Julia Frimmel, Christoph Röllig, Brigitte Mohr, Heidi Altmann, David Poitz, Sven Zukunft, Katrin Schranz, Sebastian Vosberg, Karsten Spiekermann, Michael von Bergwelt, Edgar Jost, Sabine Dressler, Kerstin Schäfer-Eckart, Triantafyllos Chavakis, Daniela Aust, Korinna Jöhrens, Gustavo Baretton, Martin Bornhäuser, Philipp A. Greif, Friedrich Stölzel, Sylvia Herold, Lisa Wagenführ
Journal: Blood (2022)
Phase I Study of TQB3455, a Selective Inhibitor of IDH2 with Favorable Safety and More Potent Efficacy to IDH2-R172K Mutation, for Acute Myeloid Leukemia and Myelodysplastic Syndrome
Authors: Hao Jiang, Xudong Wei, Chunkang Chang, Hongbing Ma, Xuejun Zhang, Xiao-Jun Huang
Journal: Blood (2022)
Safety and Efficacy of the Addition of the Protein Translation Inhibitor Omacetaxine to Induction with Cytarabine and Idarubicin in Newly Diagnosed AML
Authors: Samin Houshyar, Betul Gok Yavuz, Pritesh Patel, Nadim Mahmud, Karen Sweiss, Irum Khan, Santosh L. Saraf, Damiano Rondelli, Anwar Khan, John G. Quigley
Journal: Blood (2022)
Gene Editing and Multi-Omics Reveal Novel Metabolic Vulnerabilities in t(4;14)-Associated Multiple Myeloma
Authors: Amin Sobh, Charlotte L Kaestner, Alberto Riva, Karthik Vasan, Alisha Patel, Greeshma Surapaneni, Janai Poullard, Elena Encinas, Richard Lynn Bennett, Constantine S. Mitsiades, Lawrence H. Boise, Navdeep S. Chandel, Jonathan D. Licht
Journal: Blood (2022)